← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
AppLovin became a high-margin AI advertising platform, with huge earnings growth and heavy insider selling.
The read at a glance✓ Audited against SEC data
- Growth — Revenue +70.0% to $5.48BOK
- Profitability — Net income +111.0% to $3.33BOK
- Cash quality — Operating cash flow +89.2%OK
- Margins — Operating margin +1648 bpsOK
- Capital — Buybacks +123.4% to $2.19BNote
- Insiders — 0 open-market buys / 65 sellsWatch
Business
AppLovin provides AI-powered advertising solutions that help advertisers reach users and publishers monetize inventory. Axon Ads Manager, powered by Axon AI, comprises substantially all revenue; MAX, Adjust, and Wurl extend monetization, measurement, and connected-TV distribution.
Where the revenue comes from
Fiscal 2025, as AppLovin Corp reports it. History and quarterly detail are in the app.
Leadership changes
From AppLovin Corp's own filings, the day they're filed.
- Victoria Valenzuela · Chief Administrative & Legal Officer · departureeff. 2026-07-01
- Basil Shikin · Chief Technology Officer · departureeff. 2026-07-01
- Giovanni Ge · Chief Technology Officer · appointmenteff. 2026-04-02
Latest filings
- 8-K · Company announcement2026-08-05
- 10-Q · Quarterly report2026-08-05
- 8-K · Company announcement2026-06-05
- 10-Q · Quarterly report2026-05-06
- 8-K · Company announcement2026-05-06
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about AppLovin Corp, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.